Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Know Labs Inc (OP: KNWN )

0.0810 UNCHANGED
Last Price Updated: 3:59 PM EST, Feb 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Know Labs Inc

< Previous 1 2 Next >
Know Labs Provides Update on its Intellectual Property Portfolio
From Know Labs, Inc.
Via Business Wire
Know Labs Announces Cancellation of Special Meeting of Stockholders
From Know Labs, Inc.
Via Business Wire
Know Labs Announces Reverse Stock Split Effective February 19, 2025
From Know Labs, Inc.
Via Business Wire
Know Labs, Inc. to Report First Quarter FY 2025 Results
From Know Labs, Inc.
Via Business Wire
Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2025 Results on February 14, 2025
From Know Labs, Inc.
Via Business Wire
Know Labs Technology Licensing (KTL) Announces Formalized Client Engagement
From Know Labs, Inc.
Via Business Wire
Know Labs Files Appeal to NYSE Commencement of Proceedings to Delist
From Know Labs, Inc.
Via Business Wire
The OTCQB Venture Market Records 4 Months Of Consecutive Volume Increases In OTC Market Group's Most-Active List In October
The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) increased by 8.13% in October — its second-largest monthly increase in 2022. 
Via Benzinga
Most Active On The OTC Markets In September – A Look Back As October Comes To A Close
The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) declined by 9.62% in September – its largest decline in 2022. 
Via Benzinga
Know Labs, Inc. Announces NYSE American Listing Approval
From Know Labs, Inc.
Via Business Wire
Know Labs Provides Update on IRB-Approved Internal Trial of Non-Invasive Glucose Monitoring Technology
From Know Labs, Inc.
Via Business Wire
Millions Suffering From Diabetes May Soon See Relief From Some Of The Pain And Expenses Associated
By Mark Gilman -- Benzinga 
Via News Direct
Exposures Product Safety
Millions Suffering From Diabetes May Soon See Relief From Some Of The Pain And Expenses Associated
Americans with diabetes have been relying on insulin injections to manage their illness for decades. Those injections can be painful, expensive and inconvenient. The daily invasive testing regimen adds... 
Via TheNewswire.com
Exposures Product Safety
Millions Suffering From Diabetes May Soon See Relief From Some Of The Pain And Expenses Associated
Americans with diabetes have been relying on insulin injections to manage their illness for decades. Those injections can be painful, expensive and inconvenient. The daily invasive testing regimen adds... 
Via Benzinga
This Company Reports Moving Toward FDA Approval To Provide Pain-Free Diabetes Monitoring
Caused predominantly by genetic predisposition, immune disorders and other factors, such as unhealthy diet and exercise habits, diabetes is one of the most common lifelong chronic diseases in the... 
Via Benzinga
Know Labs Files S-1 for New Share Offering, Seeks Uplist to NYSE American Exchange
From Know Labs, Inc.
Via Business Wire
Can Artificial Intelligence Predict Our Future Health?
Thousands of financial investors and Wall Street pundits advise people daily about what economic trends are coming, what stocks are hot and what is on the upswing. Those same investors and banks... 
Via Benzinga
Comparing Fitbits To Medical Devices? This Company Says Things Aren't Even Close
The health and wellness industry focused on the well-being of the body, mind and spirit has captured the globe's attention. According to management consulting firm, Mckinsey & Co., the global wellness... 
Via Benzinga
Relief May Soon Be On The Way For Diabetes Sufferers Weary Of Constant Pin Pricks, According To This Company
Last year was the 100th anniversary of the discovery of insulin, which was instrumental in improving people's lives around the world. 
Via Benzinga
Know Labs Expands Leadership Team, Adds Chief Financial Officer and Chief Product Officer, As It Gets Closer to FDA Clearance Application
From Know Labs, Inc.
Via Business Wire
Know Labs, Inc. Discusses Significance of Patented Non-Invasive Blood Glucose Monitoring Technology with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - May 10, 2022) - The Stock Day Podcast welcomed Know Labs, Inc. (OTCQB: KNWN) ("the Company"),... 
Via Newsfile
Exposures Product Safety
New Foundational Patents Secure Multiple Growth Opportunities for Know Labs and Its Bio-RFID™ Non-Invasive Diagnostic Technology
From Know Labs, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2022
Upgrades According to Consumer Edge Research, the prior rating for The Hain Celestial Group Inc (NASDAQ:HAIN) was changed from Equal-Weight to Overweight. For the second... 
Via Benzinga
Know Labs Receives IRB Approval to Begin Internal Clinical Trial of Non-Invasive Glucose Monitoring Technology Bio-RFID™
From Know Labs, Inc.
Via Business Wire
Insiders Buying Pixelworks And 4 Other Penny Stocks
The Euro surged to $1.13 against the US dollar this morning after recent data showed the Eurozone inflation increased to a new record high of 5.1% in January. Investors, meanwhile, focused on some... 
Via Benzinga
Know Labs Launches Subsidiary, AI Mind Inc., Generates $4.2M in NFT Revenue to Fund Continued Non-Invasive Glucose Monitoring Device Development
From Know Labs, Inc.
Via Business Wire
New Test Data Confirm Particle™ Bulb from Know Labs Successfully Inactivates SARS-CoV-2 Variants
From Know Labs, Inc.
Via Business Wire
New Tests Show Know Labs Bio-RFID™ Technology Delivers Blood Glucose Readings Comparable to FDA-Cleared Devices
From Know Labs, Inc.
Via Business Wire
Know Labs Expands Non-Invasive Glucose Monitoring Product Portfolio with Introduction of New KnowU™ Diagnostic Device
From Know Labs, Inc.
Via Business Wire
4 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider... 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.